Search Results

1 - 4 of 4 items :

  • "testosterone" x
  • Education, other x
Clear All
Aspects regarding the use of drugs among athletes

.P., Murphy P.W. (1999). Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study , J. Sci. Med. Sport, 2, 341-355. 38. Bhasin S., Storer T.W., Berman N., et al. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men , N. Engl. J. Med., 335, 1-7. 39. Bhasin S., Woodhouse L., Casaburi R., et al. (2001). Testosterone dose-response relationship in healthy young men , Am. J. Physiol. Endocrinol. Metab., 281, E1172-E1181. 40. Basaria S. (2010

Open access
Endocrine Abnormalities in Patients with Chronic Kidney Disease

risk in CKD: Is there a link? Nefrologia. 2013; 33: 181-87. 5. Carrero JJ, Stenvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant. 2012; 27: 4030-41. 6. Holley JL. The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis. 2004; 11: 337-41. 7. Sugiya N, Nakashima A, Takasugi N, et al. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life. Osteoporos Int. 2011; 22: 1573

Open access
in PRILOZI
On Risks and Side Effects: Does Creative Accomplishment Make us Narcissistic?

Domains of Creativity Scale (K-DOCS). Psychology of Aesthetics, Creativity, and the Arts, 11 , 216-230. Mead, N. L., Baumeister, R. F., Stuppy, A., & Vohs, K. D. (2018). Power increases the socially toxic component of narcissism among individuals with high baseline testosterone. Journal of Experimental Psychology: General, 147 , 591-596. Morf, C. C., & Rhodewalt, F. (2001). Unraveling the paradoxes of narcissism: a dynamic self-regulatory processing model. Psychological Inquiry, 14 , 177-196. Nepon, T., Flett, G. L., Hewitt, P. L., & Molnar, D. S

Open access
Pharmacogenetics and Antipsychotic Treatment Response/ Фармакогенетски Тестирања И Одговор Кон Третман Со Антипсихотоци

mRNA. Drug Metab Dispos. 2002; 30: 383-391. 32. Dai D, Tang J, Rose R, et al., Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chloropyrifos. J. Pharmacolo Exp Ther. 2001; 299: 825-831. 33. Kuehl P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A4 protomers and characterization of genetic basis of polymorphic CYP3A5 expression. Net Genet. 2001; 27 (4): 383-391. 34. van Schaik RH, de Wildt SN, van Iperen NM, et al. CYP3A4-Vpolymorphism detection by

Open access
in PRILOZI